| Entry |
|
|---|
| Name |
Methotrimeprazine;
Levomepromazine
|
|---|
| Formula |
C19H24N2OS
|
|---|
| Exact mass |
328.1609
|
|---|
| Mol weight |
328.4717
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AA Phenothiazines with aliphatic side-chain
N05AA02 Levomepromazine
D00403 Methotrimeprazine (USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00868 Levomepromazine
D00403 Methotrimeprazine
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00868 Levomepromazine
D00403 Methotrimeprazine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D00403 Methotrimeprazine (USP)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 23
1 C8x C 20.8314 -21.1134
2 C8x C 20.8314 -22.5114
3 C8x C 22.0896 -23.2103
4 C8x C 22.0896 -20.4145
5 C8y C 23.2778 -21.1134
6 C8y C 23.2778 -22.5114
7 S2x S 24.4660 -23.2103
8 N1y N 24.4660 -20.4145
9 C8y C 25.7242 -21.1134
10 C8y C 25.7242 -22.5114
11 C8x C 26.8426 -23.2103
12 C8x C 28.1008 -22.5114
13 C8y C 28.1008 -21.1134
14 C8x C 26.9125 -20.4145
15 C1b C 24.4660 -19.0164
16 C1c C 25.7242 -18.3175
17 C1b C 25.7242 -16.9195
18 C1a C 26.9125 -19.0164
19 N1c N 26.9125 -16.2205
20 C1a C 26.9125 -14.8226
21 C1a C 28.1707 -16.9195
22 O2a O 29.3207 -20.4157
23 C1a C 30.5184 -21.1137
BOND 25
1 14 9 1
2 2 3 2
3 5 6 2
4 6 7 1
5 8 15 1
6 7 10 1
7 15 16 1
8 9 8 1
9 16 17 1
10 8 5 1
11 16 18 1 #Up
12 3 6 1
13 17 19 1
14 5 4 1
15 19 20 1
16 4 1 2
17 19 21 1
18 1 2 1
19 9 10 2
20 10 11 1
21 11 12 2
22 12 13 1
23 13 14 2
24 13 22 1
25 22 23 1
|
|---|
